Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.

Am J Respir Crit Care Med · 2021 · PMC8480240 · PMID 33705665

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

A post hoc statistical analysis showed that the age (as a covariate) of the population included in the study has no effect ( P = 0.749) in the highly significant clinical improvement ( P < 0.001) obtained with MV130 when compared with placebo.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.